Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Platinum-Resistant Ovarian Cancer. Show all posts
Showing posts with label Platinum-Resistant Ovarian Cancer. Show all posts
Tuesday, February 17, 2026

FDA Files Corcept’s New Drug Application for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer

›
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to trea...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.